Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Menses Phase01:18

Menses Phase

The uterine cycle begins with the menstrual phase, which is considered day one of the cycle and typically lasts about five days. This phase is characterized by the degeneration and shedding of the stratum functionalis, the functional layer of the endometrium.
When fertilization does not occur, the corpus luteum deteriorates, causing a significant drop in the levels of estrogen and progesterone in the body. This hormonal decrease triggers the release of prostaglandins, which cause the uterine...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

System- and sample-agnostic isotropic three-dimensional microscopy by weakly physics-informed, domain-shift-resistant axial deblurring.

Nature communications·2025
Same author

Organoid co-culture model of the human endometrium in a fully synthetic extracellular matrix enables the study of epithelial-stromal crosstalk.

Med (New York, N.Y.)·2023
Same author

Infertility services integrated within the maternal health department of a public hospital in a low-income country, Rwanda.

F&S reports·2023
Same author

Take it or leave it: oophorectomy at the time of benign hysterectomy.

Current opinion in obstetrics & gynecology·2023
Same author

Adenomyosis and fertility: does adenomyosis impact fertility and does treatment improve outcomes.

Current opinion in obstetrics & gynecology·2022
Same author

A Systematic Review of Adenomyosis: It Is Time to Reassess What We Thought We Knew about the Disease.

Journal of minimally invasive gynecology·2020
Same journal

vNOTES Versus Total Laparoscopic Hysterectomy: A Randomized Controlled Trial of Pain, Opioid Use, and Quality of Recovery.

Journal of minimally invasive gynecology·2026
Same journal

De Novo Isthmocele Formation Following Cesarean Delivery in Uterus Transplant Recipients.

Journal of minimally invasive gynecology·2026
Same journal

Retroperitoneal Field Development Time as a Procedure-Specific Learning Metric in Transperitoneal Laparoscopic Para-Aortic Lymphadenectomy: A CUSUM-Based Analysis.

Journal of minimally invasive gynecology·2026
Same journal

Regarding ''Low-Pressure Versus Standard-Pressure Pneumoperitoneum in Gynecologic Laparoscopic Surgery: A Systematic Review and Meta-Analysis''.

Journal of minimally invasive gynecology·2026
Same journal

Central sensitization and hormonal therapy failure for endometriosis-related pain symptoms: a prospective study.

Journal of minimally invasive gynecology·2026
Same journal

Regarding: "Excision of Atypical Endometrioma from the Myometrium".

Journal of minimally invasive gynecology·2026
See all related articles

Related Experiment Video

Updated: May 8, 2026

Introduction of Intracapsular Rotary-cut Procedures (IRCP): A Modified Hysteromyomectomy Procedures Facilitating Fertility Preservation
05:46

Introduction of Intracapsular Rotary-cut Procedures (IRCP): A Modified Hysteromyomectomy Procedures Facilitating Fertility Preservation

Published on: January 17, 2019

Does menstrual bleeding decrease after ablation of intramural myomas? A retrospective study.

Donald I Galen1, Keith B Isaacson, Bruce B Lee

  • 1Reproductive Science Center of the San Francisco Bay Area, San Ramon, California.

Journal of Minimally Invasive Gynecology
|September 11, 2013
PubMed
Summary
This summary is machine-generated.

Radiofrequency volumetric thermal ablation (RFVTA) effectively reduces menstrual bleeding in women with intramural myomas. This minimally invasive treatment offers significant relief for heavy menstrual bleeding caused by uterine fibroids.

Keywords:
Heavy menstrual bleedingIntramural myomasLaparoscopyMenstrual blood lossRadiofrequency volumetric thermal ablationSubmucous myomasUltrasound

More Related Videos

Auricular Point Acupressure Therapy: A Safe and Effective Treatment for Postsurgical Abortion Recovery
07:28

Auricular Point Acupressure Therapy: A Safe and Effective Treatment for Postsurgical Abortion Recovery

Published on: February 3, 2026

Related Experiment Videos

Last Updated: May 8, 2026

Introduction of Intracapsular Rotary-cut Procedures (IRCP): A Modified Hysteromyomectomy Procedures Facilitating Fertility Preservation
05:46

Introduction of Intracapsular Rotary-cut Procedures (IRCP): A Modified Hysteromyomectomy Procedures Facilitating Fertility Preservation

Published on: January 17, 2019

Auricular Point Acupressure Therapy: A Safe and Effective Treatment for Postsurgical Abortion Recovery
07:28

Auricular Point Acupressure Therapy: A Safe and Effective Treatment for Postsurgical Abortion Recovery

Published on: February 3, 2026

Area of Science:

  • Gynecology
  • Minimally Invasive Surgery
  • Women's Health

Background:

  • Uterine myomas, particularly intramural fibroids, are a common cause of heavy menstrual bleeding (HMB).
  • Existing treatments for myoma-related HMB have varying efficacy and side effect profiles.
  • Radiofrequency volumetric thermal ablation (RFVTA) is an emerging minimally invasive option.

Purpose of the Study:

  • To evaluate the efficacy of laparoscopic ultrasound-guided RFVTA in reducing menstrual blood loss (MBL) in patients with intramural myomas.
  • To compare treatment outcomes based on the presence and location of myomas (intramural vs. submucosal).

Main Methods:

  • Retrospective analysis of a prospective trial involving 135 premenopausal women with HMB and uterine myomas.
  • Laparoscopic ultrasound-guided RFVTA was performed.
  • Monthly MBL was objectively measured using alkaline hematin analysis before and 12 months after treatment.

Main Results:

  • Significant reduction in MBL was observed in patients with submucous myomas (-45.1%) and those with intramural myomas (-31.8%).
  • Even intramural myomas without a submucosal component showed a significant MBL reduction (-25.0%).
  • RFVTA demonstrated clinical and statistical significance in reducing MBL across different myoma types.

Conclusions:

  • RFVTA is effective in reducing menstrual blood loss in patients with intramural myomas, even in the absence of a submucosal component.
  • This study is the first to demonstrate the efficacy of RFVTA for intramural myomas without submucosal involvement.
  • RFVTA offers a viable treatment option for heavy menstrual bleeding associated with intramural uterine fibroids.